Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant Patients
Status:
RECRUITING
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
In this study, sensitized renal transplant recipients, who present an increased risk of acute rejection, will be evaluated for the benefit of quadruple immunosuppression, adding sirolimus to the traditional scheme with tacrolimus, mycophenolate, and prednisone.
Phase:
PHASE4
Details
Lead Sponsor:
University of Sao Paulo General Hospital
Collaborators:
Carlucci G Ventura Daniel R Salomon Elias David Neto Fabiana Agena Flavio J de Paula Francine B Lemos Gislene Bezerra Helcio Rodrigues Maria da Luz Fernandes Nelson Zocoler Galante Noemia B de Lima Paschoalina Romano Patricia S Souza Vivian Onuchic